T cell responsiveness to IL-10 defines the immunomodulatory effect of costimulation blockade via anti-CD154 and impacts transplant survival

Marcos Iglesias,Darrel Bibicheff,Alexander Komin,Maria Chicco,Samantha Guinn,Brendan Foley,Giorgio Raimondi

DOI: https://doi.org/10.1101/2024.06.12.598652

2024-06-14

Abstract:Costimulation blockade (CoB)-based immunotherapy is a promising alternative to immunosuppression for transplant recipients; however, the current limited understanding of the factors that impact its efficacy restrains its clinical applicability. In this context, pro- and anti-inflammatory cytokines are being recognized as having an impact on T cell activation beyond effector differentiation. This study aims at elucidating the impact of direct IL-10 signaling in T cells on CoB outcomes. We used a full-mismatch skin transplantation model where recipients had a T cell-restricted expression of a dominant negative IL-10 receptor (10R-DN), alongside anti-CD154 as CoB therapy. Unlike wild-type recipients, 10R-DN mice failed to benefit from CoB. This accelerated graft rejection correlated with increased accumulation of T cells producing TNF-α, IFN-γ, and IL-17. In vitro experiments indicated that while lack of IL-10 signaling did not change the ability of anti-CD154 to modulate alloreactive T cell proliferation, the absence of this pathway heightened TH1 effector cell differentiation. Furthermore, deficiency of IL-10 signaling in T cells impaired Treg induction, a hallmark of anti-CD154 therapy. Overall, these findings unveil an important and novel role of IL-10 signaling in T cells that defines the success of CoB therapies and identifies a target pathway for obtaining robust immunoregulation.

Immunology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: **Determine the role of IL - 10 signaling in T cells and how it affects the efficacy of costimulatory blockade (CoB) therapy mediated by anti - CD154, especially its impact on transplant survival**. Specifically, the researchers used a completely mismatched mouse skin graft model, in which the T cells of recipient mice specifically expressed a dominant - negative mutant of the IL - 10 receptor (IL10R - DN), and costimulatory blockade treatment was carried out with anti - CD154 antibody. The main purposes of the study were to explore: 1. **Whether IL - 10 signaling is crucial for controlling transplant rejection**: Assess the importance of IL - 10 signaling by observing the graft survival time of IL - 10 knockout mice and wild - type mice after receiving CoB treatment. 2. **Whether IL - 10 signaling in T cells is a key factor for the success of CoB therapy**: Verify this hypothesis by comparing the immune responses of IL10R - DN mice and wild - type mice after receiving CoB treatment, especially the activation of T cells, effector differentiation, and the induction of regulatory T cells (Treg). 3. **How IL - 10 signaling affects the function of T cells**: Through in vitro experiments, the response of T cells to CoB treatment in the absence of IL - 10 signaling was studied, especially the differentiation of T helper 1 (TH1) cells and the induction of Treg. Overall, this paper aims to reveal the important role of IL - 10 signaling in T cells and provide new targets and strategies for improving the clinical efficacy of CoB therapy.

T cell responsiveness to IL-10 defines the immunomodulatory effect of costimulation blockade via anti-CD154 and impacts transplant survival

Efficacy of Ctla4-Ig in Preventing Acute Rejection of Fully Allogeneic Heart Allografts in Sensitized Recipients

Interleukin-10 From Marginal Zone Precursor B-Cell Subset Is Required for Costimulatory Blockade-Induced Transplantation Tolerance

IL-10 Is Critical for Regulation of Cytotoxic CD4+NKG7+ T Cells in Lung Allograft Rejection but Is Not Required for Allograft Acceptance

CD8+CD122+PD-1+ Tregs Synergize With Costimulatory Blockade of CD40/CD154, but Not B7/CD28, to Prolong Murine Allograft Survival.

Il-10 Enhances Ctl-Mediated Tumor Rejection By Inhibiting Highly Suppressive Cd4(+) T Cells And Promoting Ctl Persistence In A Murine Model Of Plasmacytoma

The Critical Role of Induced CD4+ FoxP3+ Regulatory Cells in Suppression of Interleukin-17 Production and Attenuation of Mouse Orthotopic Lung Allograft Rejection.

Regulatory T Cell Therapy for the Induction of Clinical Organ Transplantation Tolerance

An Unexpected Counter‐Regulatory Role of IL‐10 in B‐Lymphocyte‐Mediated Transplantation Tolerance

Differential induction of donor-reactive Foxp3+ regulatory T cell via blockade of CD154 vs CD40

Th1 cytokines, programmed cell death, and alloreactive T cell clone size in transplant tolerance.

CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection.

New Insights on T Cell Apoptosis in the Induction of Treg-Dependent Dominant Tolerance

Data from Autocrine Complement Inhibits IL10-Dependent T-cell–Mediated Antitumor Immunity to Promote Tumor Progression

Transplant long-surviving induced by CD40–CD40 ligand costimulation blockade is dependent on IFN-γ through its effect on CD4+CD25+ regulatory T cells

The Key Regulatory Role of Cd8 T Cell in Alloimmune Response

Costimulatory Blockade of CD154-CD40 in Combination with T-cell Lymphodepletion Results in Prevention of Allogeneic Sensitization

Regulatory-B Cell and Regulatory-T Cell Collaborate to Promote Transplantation Tolerance (126.2)

The roles of IL-2 and IL-10 enhance anti-CD45RBmAb immune inhibition in allograft skin

Transfer of Regulatory T Cells Generated Ex Vivo Modifies Graft Rejection Through Induction of Tolerogenic CD4+CD25+ Cells in the Recipient